HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Use of high-quality natural dietary supplements as accompanying therapy in patients during radical radiotherapy and chemotherapy for urological cancer

DOI: https://doi.org/10.29296/25877305-2021-11-16

D. Ganov, Candidate of Medical Sciences Altai Branch, N.N. Blokhin National Medical Research
Center of Oncology, Ministry of Health of Russia, Barnaul

The investigation enrolled 60 patients with a diagnosed localized, locally advanced or metastatic tumor. The patients were divided into 2 groups matched by age, sex, disease stage, and nature of therapy: 1) 30 patients received BioChaga (Inonotus Obliquus) and BioDihydroquercetin in addition to basic therapy (a study group); 2) 30 patients had standard therapy only (a comparison group). Additional intake of BioDihydroquercetin and BioChaga was shown to reduce the incidence of severe complications, to improve the quality of life and the tolerance of special treatment in patients with proven prostate cancer who received external beam radiation therapy according to the radical program and in those with bladder and penile cancer.

radiation therapy
accompanying therapy
prostate cancer
bladder cancer
penile cancer
Inonotus Obliquus
quality of life
side effects
prostate specific antigen
post-radiation cystitis

  1. Davydov M.I., Aksel' E.M. Statistika zlokachestvennyh novoobrazovanij v Rossii i stranah SNG v 2012 g. M.: Izdatel'skaja gruppa RONTs, 2014; 226 s. [Davydov M.I., Aksel’ E.M. Statistika zlokachestvennykh novoobrazovanii v Rossii i stranakh SNG v 2012 g. M.: Izdatel’skaya gruppa RONTs, 2014; 226 r. (in Russ.)].
  2. Kaprin A.D., Starinskij V.V., Petrova G.V. Sostojanie onkologicheskoj pomoschi naseleniju Rossii v 2014 godu. M.: FGBU «MNIOI im. P.A. Gertsena» Minzdrava Rossii, 2015 [Kaprin A.D., Starinskii V.V., Petrova G.V. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2014 godu. M.: FGBU «MNIOI im. P.A. Gertsena» Minzdrava Rossii, 2015 (in Russ.)].
  3. Chissov V.I., Alekseev B.Ja., Rusakov I.G. Onkourologija. Natsional'noe rukovodstvo. M.: GEOTAR-Media, 2012 [Chissov V.I., Alekseev B.Ya., Rusakov I.G. Onkourologiya. Natsional’noe rukovodstvo. M.: GEOTAR-Media, 2012 (in Russ.)].
  4. Aksel' E.M. Epidemiologija raka predstatel'noj zhelezy. M., 2015 [Aksel’ E.M. Epidemiologiya raka predstatel’noi zhelezy. M., 2015 (in Russ.)].
  5. Matveev B.P. Klinicheskaja onkourologija. M., 2011; 937 s. [Matveev B.P. Klinicheskaya onkourologiya. M., 2011; 937 s. (in Russ.)].
  6. Pecherskij A.V., Semiglazov V.F., Komjakov B.K. i dr. Izmenenie ekspressii retseptorov steroidnyh gormonov pri razvitii chastichnogo vozrastnogo androgennogo defitsita (PADAM). Tsitologija. 2005; 47 (4): 311–7 [Pechersky A.V., Semiglazov V.F., Komyakov B.K. et al. Changes in the expression of receptors of steroid hormones in the development of partial androgen deficiency of aging men (PADAM). Tsitologiya. 2005; 47 (4): 311–7 (in Russ.)].